Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Guo, Teng ^a   Zhang, Yongtai ^a   Zhao, Jihui ^a   Zhu, Chunyun ^a   Feng, Nianping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cellular uptake; Microdialysis; Nanostructured lipid carriers; Solid lipid nanoparticles; Transdermal delivery

Indexed keywords

ALKALOIDS; BIOCOMPATIBILITY; CYTOTOXICITY; DIALYSIS; DRUG DELIVERY; FLOW CYTOMETRY; FLUORESCENCE; METABOLITES; MOBILE SECURITY; NANOPARTICLES; NANOSYSTEMS; NITROGEN COMPOUNDS; SKIN;

CELLULAR UPTAKE; MICRO-DIALYSIS; NANOSTRUCTURED LIPID CARRIERS; SOLID LIPID NANOPARTICLE (SLN); TRANSDERMAL DELIVERY;

ATOMIC ABSORPTION SPECTROMETRY;

ALKALOID; SOLID LIPID NANOPARTICLE; ACONITINE; DRUG CARRIER; LAPPACONITINE; LIPID; NANOMATERIAL; RANACONITINE;

ACONITE; ACONITUM SINOMONTANUM; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOCOMPATIBILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; DRUG TRANSPORT; ENDOCYTOSIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATINOCYTE; LIPOSOMAL DELIVERY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NANOPHARMACEUTICS; NONHUMAN; PROCESS OPTIMIZATION; RAT; SKIN FIBROBLAST; SKIN SURFACE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; METABOLISM; SKIN; SKIN ABSORPTION; SPRAGUE DAWLEY RAT;

ACONITUM SINOMONTANUM; RATTUS;

ACONITINE; ACONITUM; ADMINISTRATION, CUTANEOUS; ANIMALS; CELL LINE; DRUG CARRIERS; HUMANS; LIPIDS; MALE; NANOSTRUCTURES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION;

EID: 84936743516     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0107-3     Document Type: Article

References (39)

1. Bisset NG (1981) Arrow poisons in China. Part II. Aconitum-botany, chemistry, and pharmacology. J Ethnopharmacol 4:247-336
2. Yang F, Ito Y (2002) Preparative separation of lappaconitine, ranaconitine, N-deacetyllappaconitine and N-deacetylranaconitine from crude alkaloids of sample Aconitum sinomontanum Nakai by high-speed counter-current chromatography. J Chromatogr A 943:219-225
3. Shi ZM, Jiang SH, Tian JH (2003) Suppository containing alkaloids from Datura and Aconitum and fatty glycerides for the treatment of ache caused by cancer. Chinese patent. CN 03150768.9
4. Xie FM, Wang HC, Shu HL, Li JH, Jiang JR, Chang JP et al (1990) Separation and characterization of the metabolic products of lappaconitine in rat urine by high-performance liquid chromatography. J Chromatogr 526:109-118
5. Guan YZ, Shi YB, Wang H (2005) Summary on the advanced research of lappaconite hydrobromide. Theory Pr Chin Med 15:1838-1840
6. Liang ZF, Lyu YP, Yuan W, Liu YL, Zhu XC (1993) Dose-effect relationship of lappaconitine. Chin Pharmacol Bull 9:146
7. Wang Q, Chen WW, Liu HL (2008) Transdermal patch of Aconitum sinomontanum, its formulation and application as anti-inflammatory and antalgic agents. Chinese patent. CN 200810224028.8
8. Cevc G, Vierl U (2010) Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 141:277-299
9. Elnaggar YS, El-Massik MA, Abdallah OY (2011) Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine 6:3195-3205
10. Manjunath K, Venkateswarlu V (2005) Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 107:215-228
11. Tiwari R, Pathak K (2011) Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 415:232-243
12. Mller RH, Radtke M, Wissing SA (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121-128
13. Negi LM, Jaggi M, Talegaonkar S (2014) Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int J Pharm 461:403-410
14. Schäfer-Korting M, Mehnert W, Korting HC (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59:427-443
15. Siekmann B, Westesen K (1994) Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination. Pharm Pharmacol Lett 3:194-197
16. Rahman HS, Rasedee A, How CW, Abdul AB, Zeenathul NA, Othman HH et al (2013) Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine. 8:2769-2781
17. Bunjes H, Unruh T (2007) Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev 59:379-402
18. Kuntsche J, Westesen K, Drechsler M, Koch HJ, Bunjes H (2004) Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs. Pharm Res 21:1834-1843
19. Fang JY, Fang CL, Liu CH, Su YH (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70:633-640
20. Bondì ML, Craparo EF, Giammona G, Cervello M, Azzolina A, Diana P et al (2007) Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies. Drug Deliv 14:61-67
21. Wang LH, Rothberg KG, Anderson RG (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pits formation. J Cell Biol 123:1107-1117
22. Verheijen I, Tourlousse D, Vanderheyden PM, Backer JP, Vauquelin G (2004) Effect of saponin and filipin on antagonist binding to AT1 receptors in intact cells. Biochem Pharmacol 67:1601-1606
23. Sit KH, Bay BH, Wong KP (1993) Effect of genistein, a tyrosine-specific protein-kinase inhibitor, on cell rouding by pH upshifting. In Vitro Cell Dev Biol Anim 29A:395-402
24. Boucrot E, Saffarian S, Massol R, Kirchhausen T, Ehrlich M (2006) Role of lipids and actin in the formation of clathrin-coated pits. Exp Cell Res 31:4036-4048
25. Iverson TG, Skotland T, Sandvig K (2011) Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies. Nano Today 6:176-185
26. Zhang W, Liu J, Zhang Q, Li X, Yu S, Yang X et al (2014) Enhanced cellular uptake and anti-proliferating effect of chitosan hydrochlorides modified genistein loaded NLC on human lens epithelial cells. Int J Pharm 471:118-126
27. Hosoi R, Matsuyama Y, Hirose S, Koyama Y, Matsuda T, Gee A et al (2009) Characterization of (14) C-acetate uptake in cultured rat astrocytes. Brain Res 1253:69-73
28. Seong K, Seo H, Ahn W, Yoo D, Cho S, Khang G et al (2011) Enhanced cytosolic drug delivery using fully biodegradable poly(amino oxalate) particles. J Control Release 152:257-263
29. Schwarz JC, Baisaeng N, Hoppel M, Löw M, Keck CM, Valenta C (2013) Ultra-small NLC for improved dermal delivery of coenyzme Q10. Int J Pharm 447:213-217
30. Mak WC, Richter H, Patzelt A, Sterry W, Lai KK, Renneberg R et al (2011) Drug delivery into the skin by degradable particles. Eur J Pharm Biopharm 79:23-27
31. Lee SG, Jeong JH, Lee KM, Jeong KH, Yang H, Kim M et al (2014) Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule. Int J Nanomedicine 9:288-289
32. Liu Y, Wang P, Sun C, Feng N, Zhou W, Yang Y et al (2010) Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers. Int J Pharm 397:155-163
33. Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ et al (2010) Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394:179-185
34. Elnaggar YS, El-Massik MA, Abdallah OY (2009) Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 380:133-141
35. Lopes R, Eleutério CV, Gonçalves LMD, Cruz MEM, Almeida AJ (2012) Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharm Sci 45:442-450
36. Chiu YL, Ho YC, Chen YM, Peng SF, Ke CJ, Chen KJ et al (2010) The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modifiedchitosan. J Control Release 146:152-159
37. Shen LN, Zhang YT, Wang Q, Xu L, Feng NP (2014) Preparation and evaluation of microemulsion-based transdermal delivery of total flavone of rhizoma arisaematis. Int J Nanomedicine 9:3453-3464
38. Manconi M, Sinico C, Caddeo C, Vila AO, Valenti D, Fadda AM (2011) Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 412:37-46
39. Han JZ, Sun J, Zhu QG, Liu JY, Hu JH, Chen F (2012) A modified LC-MS/MS method for determination of tetramethylpyrazine in microdialysis samples and calibration of home-made linear probes. Biomed Chromatogr 26:1276-1281